Atlas Trials

The Impact of Clinical Pharmacist Intervention and Dapagliflozin as Add-On Therapy in the Management of Type 2 Diabetes Mellitus.

Clinical trial NCT06719661 · COMPLETED

Trial details

NCT number
NCT06719661
Sponsor
University of Sulaimani
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2024-12-01
Primary completion
2025-05-05
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.